[Some pharmacologic properties of mono-(O-beta-hydroxyethyl)-7-rutoside in the rat].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002351:Carrageenan / Q000037:antagonists & inhibitors; D003911:Dextrans / Q000037:antagonists & inhibitors; D004487:Edema / Q000139:chemically induced / Q000473:pathology; D000431:Ethanol / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005557:Formaldehyde / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006632:Histamine; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008297:Male; D051381:Rats; D012431:Rutin / Q000008:administration & dosage / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013997:Time Factors
D003911:Dextrans; D006634:Histamine H1 Antagonists; D012702:Serotonin Antagonists; D005557:Formaldehyde; D000431:Ethanol; D012431:Rutin; D006632:Histamine; D002351:Carrageenan; D001920:Bradykinin
Sur quelques propriétés pharmacologiques du mono (O-beta-hydroxy éthyl) 7 rutoside chez le rat